Cutler Group LP Invitae Corp Call Options Transaction History

Cutler Group LP

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 01, 2023	SELL	$1.2 - $2.73 $6,840 - $15,561	-5,700 Reduced 98.28%	100 $0
Q4 2022 Feb 07, 2023	SELL	$1.71 - $3.61 $27,531 - $58,121	-16,100 Reduced 73.52%	5,800 $0
Q3 2022 Oct 25, 2022	BUY	$1.9 - $8.63 $21,850 - $99,245	11,500 Added 110.58%	21,900 $1,000
Q2 2022 Aug 04, 2022	SELL	$2.13 - $9.01 $39,405 - $166,685	-18,500 Reduced 64.01%	10,400 $0
Q1 2022 Apr 14, 2022	SELL	$6.28 - $15.59 $137,532 - $341,421	-21,900 Reduced 43.11%	28,900 $4,000
Q4 2021 Jan 18, 2022	BUY	$14.7 - $28.67 $530,670 - $1.03 Million	36,100 Added 245.58%	50,800 $41,000
Q3 2021 Oct 26, 2021	SELL	$24.31 - $33.6 $34,034 - $47,040	-1,400 Reduced 8.7%	14,700 $30,000
Q2 2021 Jul 19, 2021	SELL	$26.09 - $40.4 $430,485 - $666,600	-16,500 Reduced 50.61%	16,100 $82,000
Q1 2021 Apr 26, 2021	BUY	$33.06 - $56.93 $942,210 - $1.62 Million	28,500 Added 695.12%	32,600 $90,000
Q3 2019 Oct 28, 2019	BUY	$18.85 - $27.5 $77,285 - $112,750	4,100 New	4,100 $25,000
Q2 2018 Aug 10, 2018	SELL	$4.87 - $8.42 $21,915 - $37,890	-4,500 Closed	0 $0
Q4 2017 Jan 17, 2018	SELL	$7.86 - $9.99 $36,156 - $45,954	-4,600 Reduced 50.55%	4,500 $11,000
Q3 2017 Oct 17, 2017	BUY	$8.89 - $10.4 $80,899 - $94,640	9,100	9,100 $20,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.